Acute comitant strabismus in anti-GQ1b antibody syndrome

J Neurol. 2023 Jan;270(1):486-492. doi: 10.1007/s00415-022-11394-3. Epub 2022 Sep 29.

Abstract

Ophthalmoplegia is the diagnostic hallmark of anti-GQ1b antibody syndrome. This study aimed to define the patterns of acute comitant strabismus in patients with anti-GQ1b antibody syndromes. We retrospectively analyzed the ocular motor findings in 84 patients with anti-GQ1b antibody-associated ophthalmoplegia during the acute phases. Of the 84 patients, 11 (13%) showed acute comitant strabismus. Compared to those without, patients with acute comitant strabismus frequently showed abnormal ocular motor findings that included gaze-evoked (n = 8), spontaneous (n = 4) and positional nystagmus (n = 4), saccadic hypermetria (n = 3), head-shaking nystagmus (n = 2), pulse-step mismatch (n = 1), and impaired visual cancellation of the vestibulo-ocular reflex (n = 1, p < 0.001). On the contrary, iridoplegia (p = 0.029) and ptosis (p = 0.001) were more commonly observed in patients with paralytic (incomitant) strabismus than in those with acute comitant strabismus. Comitant strabismus can manifest during the acute phase of anti-GQ1b antibody syndromes in association with other central ocular motor abnormalities. These findings implicate that the cerebellum and/or brainstem can be the primary target of the anti-GQ1b antibodies.

Keywords: Diplopia; Fisher syndrome; Nystagmus; Strabismus.

MeSH terms

  • Brain Stem
  • Gangliosides
  • Humans
  • Miller Fisher Syndrome* / complications
  • Miller Fisher Syndrome* / diagnosis
  • Ophthalmoplegia* / etiology
  • Retrospective Studies
  • Strabismus* / etiology

Substances

  • Gangliosides